Back to FDA Applications sponsored by ABBVIE INC

FDA Drug Application 206619 by ABBVIE INC

Application Number206619
Application Type New Drug Application
Sponsor ApplicantABBVIE INC
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New combination
Therapeutic Potential Priority
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP012/19/2014N41354000 12/23/2014
AP012/19/2014N41373000 12/23/2014
AP012/19/2014N41673000 1/23/2015
AP012/19/2014N41674000 1/23/2015
AP03/25/2015SLR42292003 3/26/2015
AP03/25/2015SLR42297003 3/26/2015
AP07/20/2015SLR43430005 7/22/2015
AP07/20/2015SLR43447005 7/22/2015
AP010/13/2015SLR44204006 10/14/2015
AP010/13/2015SLR44210006 10/15/2015
AP010/22/2015SLR44273008 10/23/2015
AP010/22/2015SLR44282008 10/23/2015
AP010/22/2015SLR44299008 10/26/2015
AP04/22/2016SE845742009 4/26/2016
AP04/22/2016SE845771009 4/27/2016
AP01/28/2016SLR45049010 1/29/2016
AP01/28/2016SLR45065010 2/1/2016
AP06/21/2016SLR46403011 6/23/2016
AP06/21/2016SLR46409011 6/23/2016
AP08/17/2016SCM47285012 10/5/2016

Back to FDA Applications sponsored by ABBVIE INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.